Breast (Apr 2021)

Patients’ quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer

  • S. Tolaney,
  • I. Blancas,
  • Y.-H. Im,
  • P. Rastogi,
  • J. Brown,
  • A. Shahir,
  • A. Zimmermann,
  • F. Boyle

Journal volume & issue
Vol. 56
pp. S20 – S21

Abstract

Read online

No abstracts available.